//
sign in
Profile
by @danabra.mov
Profile
by @dansshadow.bsky.social
Profile
by @jimpick.com
AviHandle
by @danabra.mov
AviHandle
by @dansshadow.bsky.social
AviHandle
by @katherine.computer
EventsList
by @katherine.computer
ProfileHeader
by @dansshadow.bsky.social
ProfileHeader
by @danabra.mov
ProfileMedia
by @danabra.mov
ProfilePlays
by @danabra.mov
ProfilePosts
by @danabra.mov
ProfilePosts
by @dansshadow.bsky.social
ProfileReplies
by @danabra.mov
Record
by @atsui.org
Skircle
by @danabra.mov
StreamPlacePlaylist
by @katherine.computer
+ new component
Profile
Loading...
Clin epi / health economics, focus on the evidence and science, fan of sanity
Dan Ollendorf









Loading...
My only disappointment is that this does *not* involve Jon wearing jedi robes
Really important guidance. I was pleased to speak about this at #ISPORAnnual: www.ispor.org/heor-resourc...
Want to work for a fast-paced, mission-driven organization? Look no further! ICER is looking to expand our team. We're currently looking for a Communications Coordinator. Click here to learn more: grnh.se/8f5f9de13us
Join us on May 27th at 10 AM ET for an overview of ICER Scientific Advice (ISA), a new offering to advise life science companies on evidence generation strategies to support future value assessment. Register here: shorturl.at/A6KRE
Every year, we look forward to the ISPOR annual conference as an opportunity to share our work and learn more from our colleagues working in health economics outcomes research (HEOR). Click here for the full lineup of ICER speakers: icer.org/news-insight... #ISPORAnnual #ISPOR2026 #HEOR #hta
New from Institute for Clinical and Economic Review (ICER) and Verdant Research: We revisited our 2021 white paper on FDA's accelerated approval pathway. icer.org/news-insight...
ICER, in collaboration with Verdant Research, published a new white paper yesterday that examines the evolution – and perception – of the FDA accelerated approval pathway. Read here: icer.org/pressrelease...
ICER's @dano-hta.bsky.social and Woojung Lee will be speaking at the Health Technology Assessment international (HTAi)'s 2026 Annual Meeting this year in Istanbul! Learn more: htai.eventsair.com/htai-2026-is...
Looking forward to heading up North for some quality time with CDA-AMC chums!
2d
20d
1mo
1mo
1mo
2mo
2mo
2mo
2mo
Value in Health announced the publication of an ISPOR Good Practices Report providing guidance on the use of surrogate endpoint evaluation methods in health technology assessment (HTA) decision making...
www.ispor.org
ISPOR Task Force Addresses Critical Gap in Surrogate Endpoint Guidance
The ISPOR 2026 Conference will feature several ICER speakers. See our full lineup below:
icer.org
New paper, developed with input from diverse stakeholders, outlines policy options to strengthen the FDA pathway.
ISPOR 2026: Schedule of Events with ICER Speakers - ICER
Institute for Clinical and Economic Review Releases White Paper on Accelerated Approval Pathway for Prescription Drugs - ICER
icer.org
icer.org
A CDC report showing COVID vaccines cut ER visits & hospitalizations by HALF was READY to publish… then delayed. Same methodology used for years. Now critics say it contradicts Robert F. Kennedy Jr.’s vaccine views. If the science didn’t change… who did?
Dan Ollendorf
Adrianna McIntyre
Institute for Clinical and Economic Review (ICER)
Institute for Clinical and Economic Review (ICER)